Oramed Pharmaceuticals Inc reports results for the quarter ended in January - Earnings Summary

Oramed Pharmaceuticals

15/08/2024 07:51

* Oramed Pharmaceuticals Inc  ORMP.OQ  reported quarterly
adjusted
earnings of 26 cents​​ per share for the quarter ended in
January, higher than the same quarter last year, when the
company reported EPS of -3 cents.  The mean expectation of
two analysts for the quarter was for earnings of one cent per
share. Wall Street expected results to range from -2 cents to 4
cents per share.
    * Reported revenue was zero​; analysts expected $250.00
thousand. 
    * Oramed Pharmaceuticals Inc's reported EPS for the quarter
was 26
cents​.
    * The company reported quarterly net income of $10.75
million.
    * Oramed Pharmaceuticals Inc shares had fallen by 12.8% this
quarter and lost 3.0% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 150%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "hold"

Wall Street's median 12-month price target for Oramed
Pharmaceuticals Inc is $3.25 
This summary was machine generated from LSEG data August 15 at
06:51 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      0.01           0.26           Beat
 Mar. 31 2024      0.02           0.04           Beat
 Dec. 31 2023      -0.12          0.33           Beat
 Sep. 30 2023      -0.08          -0.08          Met